SCHEMBL31387231

SCHEMBL31387231

ClC(Cl)=C1CCC2(CC1)OCCO2

nearest known ligand 0.40

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
POLB P06746 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
ESR2 Q92731 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1252571 0.81 KDM4E (0.30) KDM4ELMNATP53POLBHTT
SCHEMBL2977303 0.78 HPGD (0.33) KDM4ELMNATP53POLBHTT
SCHEMBL12918303 0.74
SCHEMBL7899069 0.71
SCHEMBL19973082 0.71 ALDH1A1 (0.33) KDM4E
SCHEMBL7764434 0.71 KDM4E (0.30) KDM4ELMNATP53HTTSMN1; SMN2
SCHEMBL7766790 0.70
SCHEMBL24034274 0.70 PTPN1 (0.36) KDM4ELMNATP53POLBHTT
SCHEMBL6594728 0.69 POLB (0.31) KDM4ELMNATP53POLBHTT
SCHEMBL2650564 0.69 POLB (0.31) KDM4ELMNATP53POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024255765-A1 NOVEL COMPOUNDS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF NUPHASE THERAPEUTICS (HANGZHOU) LIMITED., CO. (CN) 2024-12-19 WO disclosed